Leukotrien D4

Leukotrien D4
Identifikacija
CAS registarski broj 73836-78-9 DaY
PubChem[1][2] 5280878
MeSH Leukotriene+D4
ChEMBL[3] CHEMBL288943 DaY
Jmol-3D slike Slika 1
SMILES

CCCCC\C=C/C\C=C/C=C/C=C/[C@@H](SC[C@H](N)C(=O)NCC(=O)O)[C@@H](O)CCCC(=O)O

Svojstva
Molekulska formula C25H40N2O6S
Molarna masa 496,661 g/mol

 DaY (šta je ovo?)   (verifikuj)

Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje (25 °C, 100 kPa) materijala

Infobox references

Leukotrien D4 je leukotrien.

Reference

  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit

Literatura

  • Lipkowitz, Myron A. and Navarra, Tova (2001) The Encyclopedia of Allergies (2nd ed.) Facts on File, New York, p. 167, ISBN 0-8160-4404-X
  • Samuelsson, Bengt (ed.) (2001) Advances in prostaglandin and leukotriene research: basic science and new clinical applications: 11th International Conference on Advances in Prostaglandin and Leukotriene Research: Basic Science and New Clinical Applications, Florence, Italy, June 4–8, 2000 Kluwer Academic Publishers, Dordrecht, ISBN 1-4020-0146-0
  • Bailey, J. Martyn (1985) Prostaglandins, leukotrienes, and lipoxins: biochemistry, mechanism of action, and clinical applications Plenum Press, New York, ISBN 0-306-41980-7

}{refend}}

Spoljašnje veze

Portal Hemija
  • p
  • r
  • u
PrekursorProstanoidi
Prekursor
H2
Aktivni
D/J
D2
E/F
E2 (Dinoproston): Enprostil  Sulproston

E1 (Alprostadil): Mizoprostol  Gemeprost

F (Dinoprost): Bimatoprost  Karboprost  Latanoprost  Tafluprost  Travoprost  Unoproston
I
I2 (Prostaciklin/Epoprostenol): Beraprost  Iloprost  Treprostinil
A2  B2
Leukotrieni (LT)
Prekursor
Inicijalni
A4  B4
C4  D4  E4
Neklasični
Lipoksini (A4, B4 Virodhamin
Po funkciji
bronhokonstrikcija (PGF, TXA2, LTC4, LTD4, LTE4)

vazokonstrikcija (PGF, TXA2, TXB2 vazodilatacija (PGE2, PGI2, LTC4, LTD4, LTE4)

trombociti: indukuje (TXA2) inhibira (PGD2, PGI2 leukociti: indukuje (TXA2, LTB4) inhibira (PGD2, PGE2)

Porođaj stimulacija: (PGE2 (Dinoproston), PGF (Dinoprost))

M: MET

mt, k, c/g/r/p/y/i, f/h/s/l/o/e, a/u, n, m

k, cgrp/y/i, f/h/s/l/o/e, au, n, m, epon

m (A16/C10), i (k, c/g/r/p/y/i, f/h/s/o/e, a/u, n, m)

Biohemijske familije: Ugljeni hidrati (Glikozidi,Alkoholi) • Lipidi (Steroidi,Fosfolipidi,Glikolipidi,Masne kiseline,Tetrapiroli) • Proteini (Aminokiseline,Peptidi,Glikoproteini) • Nukleobaze/Nukleinske kiseline